Abstract
Treatment duration varies with the type of therapy and a patient's recovery speed. Including such a variation in randomized controlled trials (RCTs) enables comparison of the actual therapeutic potential of different therapies in clinical care. An index, Treatment Duration Control (TDC) of outcome scores was developed to help decide when to end treatment and also to determine treatment outcome by a blinded assessor. In contrast to traditional Routine Outcome Monitoring which considers raw score changes, TDC uses relative change.
Original language | English |
---|---|
Pages (from-to) | 123 |
Journal | BMC Medical Research Methodology |
Volume | 13 |
DOIs | |
Publication status | Published - 2013 |
Keywords
- Arthralgia
- Chronic Pain
- Clinical Protocols
- Humans
- Long-Term Care
- Pain Measurement
- Quality of Life
- Randomized Controlled Trials as Topic
- Temporomandibular Joint Disorders
- Treatment Outcome